---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-267485"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2026-06-11T20:05:08+00:00"
generated_at: "2026-06-11T20:11:31.651038+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Design Therapeutics stockholders elect director, ratify auditor at annual meeting

## Summary
- Simeon George, M.D., elected Class II director; 29,205,208 votes for, 7,608,724 withheld, 13,264,883 broker non-votes.
- Ernst & Young ratified as independent auditor for FY 2026; 50,077,708 votes for, 201 against, 906 abstentions.
- Record date April 14, 2026; 62,441,429 shares outstanding and entitled to vote.

## SEC filing metadata
- accession: 0001193125-26-267485
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2026-06-11T20:05:08+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000119312526267485/0001193125-26-267485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000119312526267485/dsgn-20260609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-267485
- JSON: https://secwatch.observer/filing/0001193125-26-267485.json
- Plain text: https://secwatch.observer/filing/0001193125-26-267485.txt

## Key facts
- Shareholder Votes
  Design Therapeutics, Inc. shareholders approved Election of Director at the 2026-06-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Proposal 1. Election of Director The Company’s stockholders elected the one person listed below as a Class II director, to serve until the Company’s 2029 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or, if sooner, until his death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Simeon George, M.D. 29,205,208 7,608,724 13,264,883
  evidence_url: https://www.sec.gov/Archives/edgar/data/1807120/000119312526267485/0001193125-26-267485-index.htm
- Shareholder Votes
  Design Therapeutics, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Proposal 2. Ratification of Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 50,077,708 201 906 Not applicable
  evidence_url: https://www.sec.gov/Archives/edgar/data/1807120/000119312526267485/0001193125-26-267485-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.